CALB (03931) plans to acquire an 8.4958% equity interest in CALB Technology (Wuhan) for RMB 692 million.

CALB (03931) announced that on October 14, 2026, the Company successfully won the bid in a public tender held at the China Beijing Equity Exchange (CBEX) for the target equity offered for sale by the seller Wuhan Jingkai Investment Co., Ltd. Accordingly, the Company entered into an equity transaction contract with the seller to acquire the target equity for a cash consideration of RMB 692 million. The "target equity" refers to the 8.4958% equity interest in the target company CALB Technology (Wuhan) Co., Ltd. that the Company intends to acquire under the equity transaction contract. Upon completion of this acquisition, the Company's equity interest in the target company will increase from 59.3155% to 67.8113%, and the target company will continue to be a non-wholly-owned subsidiary of the Company. CALB Technology (Wuhan) Co., Ltd. is a limited liability company established under Chinese law, principally engaged in the research and development, production, sales, and market application development of lithium batteries, battery management systems, and related integrated products. As a subsidiary of the Group, the Wuhan company has achieved sustained and stable revenue growth in recent years, with good profitability and a controllable debt-to-asset ratio. Based on favorable expectations for the development of the Wuhan company, the Company participated in the public tender, and the completion of this acquisition will further increase the Company's shareholding ratio in the Wuhan company.